Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
One of the biggest benefits of Medicare Advantage, according to its proponents, is its ability to reduce low-value care — the delivery of services that provide little or no clinical benefit — via its capitated payment...
-
Just weeks into the 2025 Annual Election Period (AEP), several major insurers stopped paying broker commissions for new enrollments into certain Medicare Advantage products. Now, sources say more...
HEALTH PLAN WEEKLY
-
Merger and acquisition (M&A) activity among insurers has led to “stubbornly” high concentration in insurance markets, according to a report from the American Medical Association. And while the Department of...
-
The U.S. health care system is currently ill-equipped to meet the high and growing need for behavioral health services, and states need to take efforts to mitigate related workforce shortages, according to a...
Radar On Speciality Pharmacy
-
Almost one year after the FDA put its approval decision on hold, Lilly has finally crossed the finish line with Ebglyss (lebrikizumab-lbkz). The approval means another option for the treatment of atopic dermatitis...
-
How the FDA fares during President-elect Donald Trump’s second term will depend, in part, on the pharmaceutical industry’s support for the agency and its staff, Commissioner Robert Califf told the Friends of...
RADAR ON DRUG BENEFITS
-
Small-molecule drugs and biologics may produce similar health benefits, but because small molecules tend to be priced lower than biologics, they often represent better value, according to a recent...
-
Employer plan sponsors in recent years have struggled to contain the costs associated with the increasing demand from beneficiaries to use GLP-1 medications for obesity and diabetes. For instance, Aon,...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.